SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-006921
Filing Date
2018-03-28
Accepted
2018-03-28 08:50:29
Documents
9
Period of Report
2018-03-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20180323.htm 8-K 58630
2 EX-3.1 xene-ex31_8.htm EX-3.1 126382
3 EX-4.1 xene-ex41_7.htm EX-4.1 1390
4 EX-10.1 xene-ex101_6.htm EX-10.1 198618
5 EX-99.1 xene-ex991_9.htm EX-99.1 13571
6 GRAPHIC g2018032803583996429431.jpg GRAPHIC 97930
7 GRAPHIC g2018032803583929231798.jpg GRAPHIC 5126
8 GRAPHIC g2018032803583998729432.jpg GRAPHIC 67976
9 GRAPHIC g2018032803585162931798.jpg GRAPHIC 6849
  Complete submission text file 0001564590-18-006921.txt   645640
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 18717106
SIC: 2834 Pharmaceutical Preparations